Guangxi Wuzhou Zhongheng Group Co Ltd

SHG:600252 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.14 Billion
CN¥8.34 Billion CNY
Market Cap Rank
#7451 Global
#1267 in China
Share Price
CN¥2.62
Change (1 day)
-0.38%
52-Week Range
CN¥2.23 - CN¥3.01
All Time High
CN¥7.62
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicines; and xueshuantong for shooting, zhonghua dieda pills, angong niuhuang pills, shedan chuanbei liquid, fuyanjing capsules, jieshitong tablets, yanjianning tablets, sodium fluorescein injection under the Zhon… Read more

Guangxi Wuzhou Zhongheng Group Co Ltd (600252) - Net Assets

Latest net assets as of September 2025: CN¥7.26 Billion CNY

Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has net assets worth CN¥7.26 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥11.06 Billion) and total liabilities (CN¥3.80 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥7.26 Billion
% of Total Assets 65.64%
Annual Growth Rate 16.12%
5-Year Change -8.67%
10-Year Change 51.67%
Growth Volatility 39.39

Guangxi Wuzhou Zhongheng Group Co Ltd - Net Assets Trend (1997–2024)

This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2024)

The table below shows the annual net assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2024.

Year Net Assets Change
2024-12-31 CN¥7.51 Billion -9.21%
2023-12-31 CN¥8.28 Billion -0.15%
2022-12-31 CN¥8.29 Billion -4.61%
2021-12-31 CN¥8.69 Billion +5.62%
2020-12-31 CN¥8.23 Billion +28.61%
2019-12-31 CN¥6.40 Billion +7.88%
2018-12-31 CN¥5.93 Billion +5.96%
2017-12-31 CN¥5.60 Billion +5.09%
2016-12-31 CN¥5.33 Billion +7.48%
2015-12-31 CN¥4.95 Billion -16.27%
2014-12-31 CN¥5.92 Billion +60.41%
2013-12-31 CN¥3.69 Billion +18.80%
2012-12-31 CN¥3.11 Billion +55.23%
2011-12-31 CN¥2.00 Billion +49.67%
2010-12-31 CN¥1.34 Billion +131.67%
2009-12-31 CN¥576.93 Million +27.65%
2008-12-31 CN¥451.95 Million +8.96%
2007-12-31 CN¥414.81 Million +16.21%
2006-12-31 CN¥356.94 Million -7.31%
2005-12-31 CN¥385.08 Million -19.15%
2004-12-31 CN¥476.29 Million +8.52%
2003-12-31 CN¥438.88 Million +2.47%
2002-12-31 CN¥428.29 Million +7.26%
2001-12-31 CN¥399.28 Million +6.32%
2000-12-31 CN¥375.55 Million +152.44%
1999-12-31 CN¥148.77 Million -6.31%
1998-12-31 CN¥158.79 Million +19.50%
1997-12-31 CN¥132.88 Million --

Equity Component Analysis

This analysis shows how different components contribute to Guangxi Wuzhou Zhongheng Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6070.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.92 Billion 31.92%
Common Stock CN¥3.35 Billion 55.69%
Other Comprehensive Income CN¥859.08 Million 14.26%
Total Equity CN¥6.02 Billion 100.00%

Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Market Cap

The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their market capitalization.

Company Market Cap
Brookline Bancorp Inc
NASDAQ:BRKL
 		$970.23 Million
Sunward Intelligent Equipment Co Ltd
SHE:002097
 		$970.29 Million
Fidelis Insurance Holdings Limited
NYSE:FIHL
 		$970.51 Million
SUFA Technology Industry Co Ltd CNNC
SHE:000777
 		$970.60 Million
IRB Infrastructure Developers Limited
NSE:IRB
 		$969.73 Million
Yunnan Botanee Bio-Technology Group Co Ltd
SHE:300957
 		$969.48 Million
Shanghai Chinafortune Co Ltd
SHG:600621
 		$969.43 Million
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
 		$969.35 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Guangxi Wuzhou Zhongheng Group Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 6,569,449,409 to 6,022,749,391, a change of -546,700,018 (-8.3%).
  • Net loss of 376,979,139 reduced equity.
  • Dividend payments of 90,891,996 reduced retained earnings.
  • Share repurchases of 279,146,298 reduced equity.
  • Other comprehensive income increased equity by 852,343,584.
  • Other factors decreased equity by 652,026,169.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-376.98 Million -6.26%
Dividends Paid CN¥90.89 Million -1.51%
Share Repurchases CN¥279.15 Million -4.63%
Other Comprehensive Income CN¥852.34 Million +14.15%
Other Changes CN¥-652.03 Million -10.83%
Total Change CN¥- -8.32%

Book Value vs Market Value Analysis

This analysis compares Guangxi Wuzhou Zhongheng Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.47x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 32.84x to 1.47x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.08 CN¥2.62 x
1998-12-31 CN¥0.10 CN¥2.62 x
1999-12-31 CN¥0.09 CN¥2.62 x
2000-12-31 CN¥0.23 CN¥2.62 x
2001-12-31 CN¥0.25 CN¥2.62 x
2002-12-31 CN¥0.26 CN¥2.62 x
2003-12-31 CN¥0.28 CN¥2.62 x
2004-12-31 CN¥0.28 CN¥2.62 x
2005-12-31 CN¥0.21 CN¥2.62 x
2006-12-31 CN¥0.23 CN¥2.62 x
2007-12-31 CN¥0.26 CN¥2.62 x
2008-12-31 CN¥0.34 CN¥2.62 x
2009-12-31 CN¥0.18 CN¥2.62 x
2010-12-31 CN¥0.44 CN¥2.62 x
2011-12-31 CN¥0.61 CN¥2.62 x
2012-12-31 CN¥0.95 CN¥2.62 x
2013-12-31 CN¥1.12 CN¥2.62 x
2014-12-31 CN¥1.71 CN¥2.62 x
2015-12-31 CN¥1.43 CN¥2.62 x
2016-12-31 CN¥1.52 CN¥2.62 x
2017-12-31 CN¥1.57 CN¥2.62 x
2018-12-31 CN¥1.74 CN¥2.62 x
2019-12-31 CN¥1.87 CN¥2.62 x
2020-12-31 CN¥2.00 CN¥2.62 x
2021-12-31 CN¥1.93 CN¥2.62 x
2022-12-31 CN¥1.90 CN¥2.62 x
2023-12-31 CN¥1.92 CN¥2.62 x
2024-12-31 CN¥1.79 CN¥2.62 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Guangxi Wuzhou Zhongheng Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -6.26%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -16.60%
  • • Asset Turnover: 0.21x
  • • Equity Multiplier: 1.82x
  • Recent ROE (-6.26%) is below the historical average (10.09%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 17.74% 16.66% 0.42x 2.56x CN¥9.70 Million
1998 16.81% 18.44% 0.39x 2.33x CN¥10.26 Million
1999 21.93% 22.42% 0.42x 2.33x CN¥16.87 Million
2000 7.12% 17.01% 0.26x 1.59x CN¥-10.61 Million
2001 7.44% 15.31% 0.28x 1.76x CN¥-10.00 Million
2002 6.61% 9.54% 0.36x 1.91x CN¥-13.92 Million
2003 6.11% 7.89% 0.31x 2.50x CN¥-17.03 Million
2004 0.48% 0.44% 0.27x 4.07x CN¥-41.52 Million
2005 -28.71% -29.62% 0.20x 4.82x CN¥-129.41 Million
2006 5.86% 6.37% 0.31x 3.00x CN¥-14.63 Million
2007 8.94% 12.80% 0.25x 2.77x CN¥-4.35 Million
2008 10.56% 7.48% 0.60x 2.35x CN¥2.48 Million
2009 22.14% 17.65% 0.47x 2.65x CN¥68.94 Million
2010 29.91% 28.52% 0.47x 2.23x CN¥265.32 Million
2011 18.77% 32.59% 0.30x 1.95x CN¥175.21 Million
2012 22.08% 35.15% 0.42x 1.50x CN¥374.11 Million
2013 20.15% 18.58% 0.66x 1.64x CN¥374.01 Million
2014 26.96% 49.61% 0.40x 1.36x CN¥1.00 Billion
2015 10.51% 38.73% 0.22x 1.24x CN¥25.07 Million
2016 9.20% 29.30% 0.26x 1.22x CN¥-42.81 Million
2017 10.82% 29.54% 0.30x 1.23x CN¥45.62 Million
2018 10.35% 18.59% 0.46x 1.22x CN¥20.72 Million
2019 11.65% 19.53% 0.49x 1.23x CN¥105.60 Million
2020 8.22% 15.31% 0.31x 1.75x CN¥-122.13 Million
2021 4.63% 9.71% 0.27x 1.80x CN¥-355.41 Million
2022 1.21% 2.91% 0.23x 1.80x CN¥-572.75 Million
2023 1.28% 2.72% 0.27x 1.78x CN¥-572.64 Million
2024 -6.26% -16.60% 0.21x 1.82x CN¥-979.25 Million

Industry Comparison

This section compares Guangxi Wuzhou Zhongheng Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Guangxi Wuzhou Zhongheng Group Co Ltd (600252) CN¥7.26 Billion 17.74% 0.52x $969.96 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million